Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nevro Corp (NVRO)
NYSE:NVRO
Nevro Corp (NVRO) Stock Price & Analysis
195 Followers
NVRO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.93 - $28.42
Previous Close$9.35
Volume396.47K
Average Volume (3M)522.89K
Market Cap
$343.41M
Enterprise Value$279.83M
Total Cash (Recent Filing)$281.48M
Total Debt (Recent Filing)$217.90M
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Jul 31, 2024EPS Estimate
-$0.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.28
Shares Outstanding36,728,648
10 Day Avg. Volume590,778
30 Day Avg. Volume522,893
Standard Deviation0.14
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.58
Price to Sales (P/S)0.81
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.65
Enterprise Value/Gross Profit0.96
Enterprise Value/Ebitda-8.81
Forecast
1Y Price Target
$14.69Price Target Upside57.11% Upside
Rating ConsensusHold
Number of Analyst Covering13
Nevro Corp News
PremiumCompany Announcements
Nevro Corp Announces Christoforou as New COO With Incentives
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe introduction of Vyrsa is expected to be accretive to adjusted EBITDA, with growing market share projections.
Product AcceptanceThe company's newest generation SCS platform, HFX iQ, is gaining traction, now making up a larger portion of permanent implants.
Restructuring BenefitsRestructuring efforts on track to generate over $30M in annualized cost-savings in FY24, which should position the company to drive increasing leverage.
Bears Say
Financial PerformanceFY24 growth remains sedated, and the below-CNS Q2-guide doesn't give confidence NVRO is out of the woods yet.
Market ChallengesAnalysts have a less optimistic view on a strong recovery in the core spinal cord stimulation market.
Profitability ConcernsDespite some growth, the company is still forecasted to have a sizable net loss for the year, indicating ongoing profitability challenges.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NVRO FAQ
What was Nevro Corp’s price range in the past 12 months?
Nevro Corp lowest stock price was $8.93 and its highest was $28.42 in the past 12 months.
What is Nevro Corp’s market cap?
Currently, no data Available
When is Nevro Corp’s upcoming earnings report date?
Nevro Corp’s upcoming earnings report date is Jul 31, 2024 which is in 60 days.
How were Nevro Corp’s earnings last quarter?
Nevro Corp released its earnings results on May 07, 2024. The company reported -$0.7 earnings per share for the quarter, beating the consensus estimate of -$1.054 by $0.354.
Is Nevro Corp overvalued?
According to Wall Street analysts Nevro Corp’s price is currently Undervalued.
Does Nevro Corp pay dividends?
Nevro Corp does not currently pay dividends.
What is Nevro Corp’s EPS estimate?
Nevro Corp’s EPS estimate is -$0.7.
How many shares outstanding does Nevro Corp have?
Nevro Corp has 36,728,650 shares outstanding.
What happened to Nevro Corp’s price movement after its last earnings report?
Nevro Corp reported an EPS of -$0.7 in its last earnings report, beating expectations of -$1.054. Following the earnings report the stock price went down -11.882%.
Which hedge fund is a major shareholder of Nevro Corp?
Among the largest hedge funds holding Nevro Corp’s share is Engaged Capital LLC. It holds Nevro Corp’s shares valued at 27M.
---
Nevro Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.69 (57.11% Upside)
$14.69 (57.11% Upside)
Blogger Sentiment
Bullish
NVRO Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 8.5K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-66.07%
12-Months-Change
Fundamentals
Return on Equity
-28.49%
Trailing 12-Months
Asset Growth
3.76%
Trailing 12-Months
Company Description
Nevro Corp
Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
---
NVRO Company Deck
---
NVRO Earnings Call
Q1 2024
0:00 / 0:00
---
NVRO Stock 12 Month Forecast
Average Price Target
$14.69
▲(57.11% Upside)
Technical Analysis
Best Analysts Covering NVRO
1 Year
1 Year Success Rate
10/22 ratings generated profit
1 Year Average Return
-0.35%
downgraded a sell rating 11 days ago
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of -0.35% per trade.
---